Skip to main content
KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc. — Investor Relations & Filings

Ticker · KRMD ISIN · US7599101026 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2023-12-15 Director's Dealing
Country US United States of America
Listing US KRMD

About KORU Medical Systems, Inc.

https://www.korumedical.com/

KORU Medical Systems is a medical technology company that designs, develops, manufactures, and commercializes subcutaneous infusion solutions. The company's primary offering is the Freedom™ Infusion System, which includes syringe infusion pumps and related accessories. These systems are engineered for the delivery of large-volume subcutaneous drugs, such as immunoglobulins, to treat patients with chronic illnesses. KORU Medical Systems focuses on providing patient-centric solutions that facilitate safe and effective home-based infusion therapy, aiming to enhance patient quality of life by offering greater freedom and flexibility in treatment management.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2023-12-15 English
FORM 4/A AMENDMENT NO. 2 FOR 09-30-2021
Director's Dealing
2023-12-12 English
FORM 4 FOR 11-15-2023
Director's Dealing
2023-11-17 English
FORM 3 FOR 11-06-2023
Director's Dealing
2023-11-09 English
FORM 10-Q QUARTERLY REPORT FOR 09-30-2023
Interim / Quarterly Report Q3 2023
2023-11-08 English
FORM 8-K CURRENT REPORT FOR 11-06-2023
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes: (1) financial results for the third quarter ended September 30, 2023, announced via a press release and a related conference call; (2) appointment of a new executive officer (Chief Commercial Officer) with detailed terms of employment and stock option awards; (3) FDA clearance announcement; and (4) references to press releases and employment agreements as exhibits. The document is not a full quarterly or annual report but a current report announcing multiple material events including financial results and management changes. The financial results are announced via a press release (Exhibit 99.1) and a conference call, but the 8-K itself does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). The appointment of a new executive officer is a management change. Given the multiple types of information, the primary purpose is to announce current material events rather than provide a full financial report. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit neatly into other categories. Confidence is high because the document is a standard Form 8-K with multiple announcements and no full financial statements or detailed management discussion sections.
2023-11-08 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.